# HNF1A

## Overview
The HNF1A gene encodes the hepatocyte nuclear factor 1A (HNF-1A) protein, a transcription factor that plays a pivotal role in regulating gene expression in various tissues, including the liver, pancreas, and kidneys. As a transcription factor, HNF-1A is involved in the control of genes essential for glucose metabolism and insulin secretion, thereby maintaining glucose homeostasis. Structurally, the HNF-1A protein comprises a dimerization domain, a DNA-binding domain, and a transactivation domain, which facilitate its function in gene regulation through protein-DNA and protein-protein interactions (Kind2021Structural; Kind2023Structural). Mutations in the HNF1A gene are linked to maturity-onset diabetes of the young type 3 (MODY3) and other metabolic disorders, highlighting its clinical significance in diabetes and related conditions (Li2022HNF1A：From; Ellard2006Mutations).

## Structure
The HNF1A gene encodes the hepatocyte nuclear factor 1A (HNF-1A) protein, a transcription factor with a multi-domain structure crucial for its function. The protein consists of an N-terminal dimerization domain (DD), a central DNA-binding domain (DBD), and a C-terminal transactivation domain (TAD) (Kind2021Structural; Balamurugan2016Structure–function). The DD is a 32-residue α-helical region that facilitates dimerization, forming a heterotetramer with PCBD1, which stabilizes the dimeric form of HNF-1A (Kind2021Structural). The DBD includes a Pit-Oct-Unc-specific (POUS) domain and a homeodomain (POUH), which bind to specific DNA sequences, with a nuclear-localization signal ensuring its translocation into the nucleus (Kind2021Structural).

The TAD is predominantly disordered, containing long intrinsically disordered regions (IDRs) that may undergo disorder-to-order transitions upon binding to partner proteins, which is crucial for its role in gene transcriptional regulation (Kind2023Structural). This domain is involved in forming macromolecular complexes and interacting with multiple transcription factors and co-activators, providing versatility in protein-protein interactions (Kind2023Structural). The disordered nature of the TAD is suggested to aid in DNA recognition and binding, modulating HNF-1A's transcriptional activity (Kind2023Structural).

## Function
The HNF1A gene encodes a transcription factor that plays a crucial role in regulating gene expression in liver, kidney, and pancreatic cells. In healthy human cells, HNF1A is essential for maintaining normal β-cell function and insulin secretion, which are critical for glucose homeostasis. It regulates genes involved in glucose metabolism, such as glucose transporter 2 (GLUT2), liver pyruvate kinase, and insulin, ensuring proper glucose-stimulated insulin secretion (GSIS) (Sujjitjoon2020Defective; Shih2001Loss).

HNF1A is involved in the transcriptional regulation of genes necessary for β-cell stimulus-secretion coupling, including those in the glycolytic pathway, the tricarboxylic acid (TCA) cycle, and mitochondrial oxidative phosphorylation (Servitja2009Hnf1α). It also influences the expression of transcription factors such as HNF-4α, Pdx-1, and Neuro-D1/Beta-2, which are important for β-cell function and development (Shih2001Loss).

In the liver, HNF1A regulates genes associated with metabolic functions, including lipogenesis and carbohydrate metabolism, and is involved in maintaining normal liver metabolism (Servitja2009Hnf1α). The gene's function is highly tissue-specific, with distinct roles in pancreatic islets and liver, impacting cell growth and metabolism (Servitja2009Hnf1α).

## Clinical Significance
Mutations in the HNF1A gene are primarily associated with maturity-onset diabetes of the young type 3 (MODY3), a monogenic form of diabetes characterized by autosomal dominant inheritance and early onset, often before the age of 25. These mutations lead to pancreatic beta-cell dysfunction, resulting in impaired insulin secretion and hyperglycemia (Colclough2013Mutations; Ellard2006Mutations). HNF1A mutations are highly penetrant, with a significant percentage of carriers developing diabetes by age 25, 50, and 75 (Ellard2006Mutations).

The gene is also implicated in gestational diabetes mellitus (GDM), where specific polymorphisms like Gly288fs* and p.I27L increase the risk by causing beta-cell dysfunction and glucose intolerance during pregnancy (Li2022HNF1A：From). HNF1A mutations can lead to dyslipidemia, affecting lipid metabolism and increasing cardiovascular risk factors in diabetic individuals (Li2022HNF1A：From).

In some cases, HNF1A mutations are linked to liver adenomatosis, characterized by multiple liver nodules, which can lead to severe complications such as hemorrhage. This condition may result from further somatic mutations in the liver (Reznik2004Hepatocyte). The clinical phenotype of HNF1A-related diabetes can vary, influenced by the specific mutation type and its position within the gene (Harries2006Isomers).

## Interactions
HNF1A, a transcription factor, engages in various protein-protein and protein-DNA interactions that are crucial for its function in gene regulation. It interacts with high mobility group box 1 (HMGB1), which acts as a cofactor enhancing HNF1A's transcriptional activity by promoting its binding to DNA. This interaction is facilitated by the homeobox domain of HNF1A and the HMG box of HMGB1, excluding the acidic tail of HMGB1 (Yu2007Proteomic). HNF1A also forms complexes with other proteins such as HNF4, RANBP1, 14-3-3zeta, and CBX3, as identified through co-immunoprecipitation and mass spectrometry analyses (Yu2007Proteomic).

HNF1A interacts with KPNA proteins, particularly KPNA6, which has the highest binding affinity. This interaction involves hydrophobic and hydrophilic interactions, and mutations in HNF1A can significantly reduce this binding affinity (Fareed2021HNF1AMODY). Additionally, HNF1A is involved in interactions with transcription activators like CTNNB1, PCBD1, and PCBD2, which enhance its transcriptional activity. It also interacts with proteins involved in glucose metabolism, such as G6PC and SLC2A2, and with PDX1 in pancreatic cells, which is crucial for maintaining hormone production (Sneha2018Probing). These interactions highlight HNF1A's role in forming multiprotein complexes that regulate tissue-specific gene expression.


## References


[1. (Colclough2013Mutations) Kevin Colclough, Christine Bellanne-Chantelot, Cecile Saint-Martin, Sarah E. Flanagan, and Sian Ellard. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Human Mutation, 34(5):669–685, April 2013. URL: http://dx.doi.org/10.1002/humu.22279, doi:10.1002/humu.22279. This article has 173 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22279)

[2. (Servitja2009Hnf1α) Joan-Marc Servitja, Miguel Pignatelli, Miguel Ángel Maestro, Carina Cardalda, Sylvia F. Boj, Juanjo Lozano, Enrique Blanco, Amàlia Lafuente, Mark I. McCarthy, Lauro Sumoy, Roderic Guigó, and Jorge Ferrer. Hnf1α (mody3) controls tissue-specific transcriptional programs and exerts opposed effects on cell growth in pancreatic islets and liver. Molecular and Cellular Biology, 29(11):2945–2959, June 2009. URL: http://dx.doi.org/10.1128/mcb.01389-08, doi:10.1128/mcb.01389-08. This article has 111 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01389-08)

[3. (Shih2001Loss) David Q. Shih, Seamus Screenan, Karla N. Munoz, Lou Philipson, Marco Pontoglio, Moshe Yaniv, Kenneth S. Polonsky, and Markus Stoffel. Loss of hnf-1α function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes, 50(11):2472–2480, November 2001. URL: http://dx.doi.org/10.2337/diabetes.50.11.2472, doi:10.2337/diabetes.50.11.2472. This article has 179 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.2337/diabetes.50.11.2472)

[4. (Balamurugan2016Structure–function) K. Balamurugan, L. Bjørkhaug, S. Mahajan, S. Kanthimathi, P.R. Njølstad, N. Srinivasan, V. Mohan, and V. Radha. Structure–function studies of <scp>hnf1a</scp> (<scp>mody3</scp>) gene mutations in south indian patients with monogenic diabetes. Clinical Genetics, 90(6):486–495, March 2016. URL: http://dx.doi.org/10.1111/cge.12757, doi:10.1111/cge.12757. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/cge.12757)

[5. (Li2022HNF1A：From) Li-Mei Li, Bei-Ge Jiang, and Liang-Liang Sun. Hnf1a：from monogenic diabetes to type 2 diabetes and gestational diabetes mellitus. Frontiers in Endocrinology, March 2022. URL: http://dx.doi.org/10.3389/fendo.2022.829565, doi:10.3389/fendo.2022.829565. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fendo.2022.829565)

[6. (Harries2006Isomers) Lorna W. Harries, Sian Ellard, Amanda Stride, Noel G. Morgan, and Andrew T. Hattersley. Isomers of the tcf1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. Human Molecular Genetics, 15(14):2216–2224, June 2006. URL: http://dx.doi.org/10.1093/hmg/ddl147, doi:10.1093/hmg/ddl147. This article has 97 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddl147)

[7. (Reznik2004Hepatocyte) Yves Reznik, Thong Dao, Regis Coutant, Laurence Chiche, Emmanuelle Jeannot, Severine Clauin, Pierre Rousselot, Monique Fabre, Frederic Oberti, Armelle Fatome, Jessica Zucman-Rossi, and Christine Bellanne-Chantelot. Hepatocyte nuclear factor-1α gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (mody)3 families. The Journal of Clinical Endocrinology &amp; Metabolism, 89(3):1476–1480, March 2004. URL: http://dx.doi.org/10.1210/jc.2003-031552, doi:10.1210/jc.2003-031552. This article has 111 citations.](https://doi.org/10.1210/jc.2003-031552)

[8. (Fareed2021HNF1AMODY) Fareed M. A. Fareed, Sirin Korulu, Mehmet Özbil, and Özlem Yalçın Çapan. Hnf1a-mody mutations in nuclear localization signal impair hnf1a-import receptor kpna6 interactions. The Protein Journal, 40(4):512–521, January 2021. URL: http://dx.doi.org/10.1007/s10930-020-09959-0, doi:10.1007/s10930-020-09959-0. This article has 1 citations.](https://doi.org/10.1007/s10930-020-09959-0)

[9. (Sneha2018Probing) P. Sneha, D. Thirumal Kumar, Jose Lijo, M. Megha, R. Siva, and C. George Priya Doss. Probing the Protein–Protein Interaction Network of Proteins Causing Maturity Onset Diabetes of the Young, pages 167–202. Elsevier, 2018. URL: http://dx.doi.org/10.1016/bs.apcsb.2017.07.004, doi:10.1016/bs.apcsb.2017.07.004. This article has 14 citations.](https://doi.org/10.1016/bs.apcsb.2017.07.004)

10. (Kind2021Structural) Structural and biophysical characterization of HNF-1A as a tool to study MODY3 diabetes variants. This article has 0 citations.

[11. (Yu2007Proteomic) Miao Yu, Jian Wang, Wei Li, Yan Zhi Yuan, Chang Yan Li, Xiao Hong Qian, Wang Xiang Xu, Yi Qun Zhan, and Xiao Ming Yang. Proteomic screen defines the hepatocyte nuclear factor 1α-binding partners and identifies hmgb1 as a new cofactor of hnf1α. Nucleic Acids Research, 36(4):1209–1219, December 2007. URL: http://dx.doi.org/10.1093/nar/gkm1131, doi:10.1093/nar/gkm1131. This article has 31 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm1131)

[12. (Kind2023Structural) Laura Kind, Mark Driver, Arne Raasakka, Patrick R. Onck, Pål Rasmus Njølstad, Thomas Arnesen, and Petri Kursula. Structural properties of the hnf-1a transactivation domain. Frontiers in Molecular Biosciences, October 2023. URL: http://dx.doi.org/10.3389/fmolb.2023.1249939, doi:10.3389/fmolb.2023.1249939. This article has 2 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2023.1249939)

[13. (Sujjitjoon2020Defective) Jatuporn Sujjitjoon, Chutima Charoensuk, Thanita Thanyaphon, Suwattanee Kooptiwut, Prapaporn Jungtrakoon Thamtarana, Watip Tangjittipokin, Nalinee Chongjaroen, Chutima Chanprasert, Zuroida Abubakar, Sorravis Lapbenjakul, Pa-thai Yenchitsomanus, and Nattachet Plengvidhya. Defective functions of hnf1a variants on bcl2l1 transactivation and beta-cell growth. Biochemical and Biophysical Research Communications, 529(3):826–833, August 2020. URL: http://dx.doi.org/10.1016/j.bbrc.2020.05.155, doi:10.1016/j.bbrc.2020.05.155. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2020.05.155)

[14. (Ellard2006Mutations) Sian Ellard and Kevin Colclough. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (hnf1a) and 4 alpha (hnf4a) in maturity-onset diabetes of the young. Human Mutation, 27(9):854–869, September 2006. URL: http://dx.doi.org/10.1002/humu.20357, doi:10.1002/humu.20357. This article has 140 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.20357)